May 10, 2016
Protein May Predict Response to Immunotherapy in Patients with Metastatic Melanoma
By Jeff Briggs
Biomedical research is a large part of the mission at Mayo Clinic and here at the Center for Individualized Medicine, as we wrote about in a recent blog. News of a study that was funded in part by the Center’s Biomarker Discovery Program was just announced that may help immunotherapy for patients with metastatic melanoma. […]
Tags: Bim, Bim protein, biomarker, Biomarker Discovery Program, center for individualized medicine, Dr. Haidong Dong, Dr. Roxana Dronca, immunotherapy, Melanoma, Metastatic melanoma
version 3.3.6.2.8.5
Page loaded in 0.056 seconds